![](/wp-content/uploads/2019/06/fenix-group-announcement.png)
$599
Nothing New in Sota Adcom Federal Register Announcement
Today, the FDA published a notice in the Federal Register announcing the sotagliflozin adcom for Jan 17, which was press released yesterday by Lexicon. No notable new details were provided, and the proposed indication is in-line with expectations as “…Adjunct to insulin therapy to improve glycemic control in adults with type 1 diabetes mellitus.”